Delivery Order SPE2DB22D3301-SPE2DB24FY8BD

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,563.20 Firm Fixed Price Delivery Order contract covers the supply of Pirfenidone 801 mg tablets for a period ending on March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $3,329.25. The contract is for the delivery of Pirfenidone 801 mg tablets and is designated as a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of November 29, 2024 and was awarded on November 27, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,893.12 firm fixed-price delivery order is for the supply of Pirfenidone 267 mg tablets. The contract has an ultimate completion date of November 15, 2023 and was awarded on November 14, 2023 with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,201.50 fixed-price delivery order is for the supply of Pirfenidone 267 mg tablets, a medication used to treat pulmonary fibrosis. The contract has an ultimate completion date of March 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $50,015.94 firm-fixed-price delivery order is for the supply of 90-count tablets of Pirfenidone 801 mg. The contract has an ultimate completion date of December 27, 2024 and was awarded on December 26, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FN2D0, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,573.06 fixed-price delivery order is for the supply of 4560732604 - Pirfenidone 801 mg tablets. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,055.75 firm fixed-price contract is for the delivery of 4560912851 - Pirfenidone 801 mg Tablets, 90 tablets per bottle. The contract has a completion date of May 12, 2023 and was awarded on May 11, 2023. There was no set-aside designation used for this award. AmerisourceBergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,852.07 firm fixed price delivery order is for the supply of PYRAZINAMIDE TABLETS, a generic pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $16,855.40 firm-fixed-price delivery order, with a completion date of December 6, 2024, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
The federal contract award is for the delivery of 4,565,321,537 units of Pirfenidone 267 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,490.97 and is a firm fixed price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has no set-aside designation and has an ultimate completion date of August 2, 2024....
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY8BD
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Pirfenidone 267 mg tablets. The $20,327.43 firm fixed-price delivery order contract has a completion date of June 6, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's significant contracting presence with DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, demonstrates its role as a key vendor for essential medical commodities to various government healthcare programs.

Generated 5/16/25, 12:38 PM